compounded tirzepatide risks methylcobalamin compound versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk will tirzepatide still be available

Trial data show that up to about 6% of people on 5 mg to 15 mg doses of Zepbound reported hair loss in studies lasting up to 72 weeks

After investing significant effort, the desire to maintain that weight without ongoing medication is natural

Initially designed to help people with type 2 diabetes keep their blood sugar in check, this single molecule has proven strikingly efficient at melting away body weight

Sleep Disruption Some patients report sleep disturbances related to gastrointestinal discomfort, particularly nausea that may worsen at night or early morning

P = .05)

Only around 1,000 people in Dorset will qualify under strict national criteria Were building a community-based weight management service to help roll this out based on patient feedback There is no need to contact your doctor More info is available at nhsdorset.nhs.uk/mounjaro | NHS Dorset